At Janssen, we believe that true innovation comes from creating and continually expanding the global “think tank” of talented and passionate pioneers. Ideas spark more ideas and turn into invention, but only in an environment of open exchange where every idea has merit. We pursue new perspectives and innovative ideas wherever they are – inside or outside our company – to work with the best scientific minds in oncology today.
Instead of waiting for a breakthrough discovery to occur before forming a partnership, we invest where we see an area of expertise that will inherently uncover innovation. And we do so in a highly focused manner. There are more than 200 cancers and we understand that we can’t be experts in each one. As an organization, we’ve committed to focusing on select Disease Area Strongholds – disease areas where we have committed to developing deep expertise. (Learn more about our Disease Area Strongholds.) What this means is that when a groundbreaking idea emerges, we are poised to rapidly move forward.
The Best of Both Worlds
Our focus in oncology matches an entrepreneurial biotech spirit within a global pharmaceutical framework. As such, we can be counted on to be active collaborators and project champions, committed to giving projects the time and attention they need to be successful.
We aim to be the partner of choice, whether joining with academia, advancing promising compounds and working with talented researchers, or forming research and development and business alliances with companies that possess complementary strengths.
Our capabilities include state-of-the-art discovery, biomarkers, companion diagnostics and global development programs of biologics and small molecules, and strong commercialization entities that market our products in more than 175 countries.
Committed to Partnering
We engage in diverse and varied partnerships at all levels of the development process.